 | • レポートコード：QYR9ST03424 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、移植片対宿主病（GVHD）治療の世界市場について調査・分析し、移植片対宿主病（GVHD）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（モノクローナル抗体、MTOR阻害剤、チロシンキナーゼ阻害剤、サリドマイド、エタネルセプト）、用途別（急性移植片対宿主病（aGvHD）、慢性移植片対宿主病（cGvHD））、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の移植片対宿主病（GVHD）治療市場動向 ・主要企業別マーケットシェア ・移植片対宿主病（GVHD）治療の種類別市場規模2014-2019 （モノクローナル抗体、MTOR阻害剤、チロシンキナーゼ阻害剤、サリドマイド、エタネルセプト） ・移植片対宿主病（GVHD）治療の用途別市場規模2014-2019 （急性移植片対宿主病（aGvHD）、慢性移植片対宿主病（cGvHD）） ・移植片対宿主病（GVHD）治療の北米市場：主要企業・種類別/用途別市場規模 ・移植片対宿主病（GVHD）治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・移植片対宿主病（GVHD）治療の中国市場：主要企業・種類別/用途別市場規模 ・移植片対宿主病（GVHD）治療の日本国内市場：主要企業・種類別/用途別市場規模 ・移植片対宿主病（GVHD）治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・移植片対宿主病（GVHD）治療のインド市場：主要企業・種類別/用途別市場規模 ・移植片対宿主病（GVHD）治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol-Myers Squibb、Abbott、AbbVie、Allergan、Anterogen、Astellas Pharma、Athersys、Caladrius、Eli Lilly、GlaxoSmithKline、Glenmark、Kadmon Holdings、Osiris Therapeutics、Sanofi、Shire） ・移植片対宿主病（GVHD）治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Graft versus Host disease occurs after a stem cell or bone marrow transplant. High dose treatment destroy cancer cells along with that it simultaneously destroys healthy cells. Stem cell and bone marrow transplant treatments are used in reconstructing damaged cells, surrounding cancer tumors. Normally after high dose treatment, patient receives bone marrow from a donor through drip which resumes production of blood cells. Graft versus Host Disease occurs when certain types of white blood cells. This is caused due to the transplanted cells (graft) see recipient’s body (host) as exotic, thus transplanted cells attack the host body.The growing number of organ transplantation cases as one of the major factors that will have a positive impact on the growth of the market. The rise in chronic diseases across the globe has led to the growth in the need for organ transplantation. It has been observed that in 2015, the US witnessed more than 30,000 organ transplants cases, which has increased about 5% when compared to the previous year. Similarly, countries such as Australia also witnesses increasing cases of organ transplantation. This rising number of organ transplants will subsequently augment the growth prospects of the GVHD treatment market.
The Americas is expected to be the major revenue contributor to the GVHD treatment market by 2021. The increasing number of transplantation procedures and the growing healthcare infrastructure, will fuel the growth prospects of the market in this region. Moreover, the increasing cases of organ failures due to the unhealthy lifestyle and dietary habits of the people and the approvals of new drugs for the treatment of GVHD, will also drive the market’s growth in this region.
In 2018, the global Graft Versus Host Disease (GVHD) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Graft Versus Host Disease (GVHD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Graft Versus Host Disease (GVHD) Treatment development in United States, Europe and China.
The key players covered in this study
Bristol-Myers Squibb
Abbott
AbbVie
Allergan
Anterogen
Astellas Pharma
Athersys
Caladrius
Eli Lilly
GlaxoSmithKline
Glenmark
Kadmon Holdings
Osiris Therapeutics
Sanofi
Shire
Market segment by Type, the product can be split into
Monoclonal Antibodies
MTOR Inhibitors
Tyrosine Kinase Inhibitors
Thalidomide
Etanercept
Market segment by Application, split into
Acute Graft Versus Host Disease (aGvHD)
Chronic Graft Versus Host Disease (cGvHD)
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Graft Versus Host Disease (GVHD) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Graft Versus Host Disease (GVHD) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Graft Versus Host Disease (GVHD) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Graft Versus Host Disease (GVHD) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 MTOR Inhibitors
1.4.4 Tyrosine Kinase Inhibitors
1.4.5 Thalidomide
1.4.6 Etanercept
1.5 Market by Application
1.5.1 Global Graft Versus Host Disease (GVHD) Treatment Market Share by Application (2014-2025)
1.5.2 Acute Graft Versus Host Disease (aGvHD)
1.5.3 Chronic Graft Versus Host Disease (cGvHD)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Graft Versus Host Disease (GVHD) Treatment Market Size
2.2 Graft Versus Host Disease (GVHD) Treatment Growth Trends by Regions
2.2.1 Graft Versus Host Disease (GVHD) Treatment Market Size by Regions (2014-2025)
2.2.2 Graft Versus Host Disease (GVHD) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Graft Versus Host Disease (GVHD) Treatment Market Size by Manufacturers
3.1.1 Global Graft Versus Host Disease (GVHD) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Graft Versus Host Disease (GVHD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Graft Versus Host Disease (GVHD) Treatment Key Players Head office and Area Served
3.3 Key Players Graft Versus Host Disease (GVHD) Treatment Product/Solution/Service
3.4 Date of Enter into Graft Versus Host Disease (GVHD) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Graft Versus Host Disease (GVHD) Treatment Market Size by Type (2014-2019)
4.2 Global Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Graft Versus Host Disease (GVHD) Treatment Market Size (2014-2019)
5.2 Graft Versus Host Disease (GVHD) Treatment Key Players in United States
5.3 United States Graft Versus Host Disease (GVHD) Treatment Market Size by Type
5.4 United States Graft Versus Host Disease (GVHD) Treatment Market Size by Application
6 Europe
6.1 Europe Graft Versus Host Disease (GVHD) Treatment Market Size (2014-2019)
6.2 Graft Versus Host Disease (GVHD) Treatment Key Players in Europe
6.3 Europe Graft Versus Host Disease (GVHD) Treatment Market Size by Type
6.4 Europe Graft Versus Host Disease (GVHD) Treatment Market Size by Application
7 China
7.1 China Graft Versus Host Disease (GVHD) Treatment Market Size (2014-2019)
7.2 Graft Versus Host Disease (GVHD) Treatment Key Players in China
7.3 China Graft Versus Host Disease (GVHD) Treatment Market Size by Type
7.4 China Graft Versus Host Disease (GVHD) Treatment Market Size by Application
8 Japan
8.1 Japan Graft Versus Host Disease (GVHD) Treatment Market Size (2014-2019)
8.2 Graft Versus Host Disease (GVHD) Treatment Key Players in Japan
8.3 Japan Graft Versus Host Disease (GVHD) Treatment Market Size by Type
8.4 Japan Graft Versus Host Disease (GVHD) Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Graft Versus Host Disease (GVHD) Treatment Market Size (2014-2019)
9.2 Graft Versus Host Disease (GVHD) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Graft Versus Host Disease (GVHD) Treatment Market Size by Type
9.4 Southeast Asia Graft Versus Host Disease (GVHD) Treatment Market Size by Application
10 India
10.1 India Graft Versus Host Disease (GVHD) Treatment Market Size (2014-2019)
10.2 Graft Versus Host Disease (GVHD) Treatment Key Players in India
10.3 India Graft Versus Host Disease (GVHD) Treatment Market Size by Type
10.4 India Graft Versus Host Disease (GVHD) Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Graft Versus Host Disease (GVHD) Treatment Market Size (2014-2019)
11.2 Graft Versus Host Disease (GVHD) Treatment Key Players in Central & South America
11.3 Central & South America Graft Versus Host Disease (GVHD) Treatment Market Size by Type
11.4 Central & South America Graft Versus Host Disease (GVHD) Treatment Market Size by Application
12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.1.4 Bristol-Myers Squibb Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Abbott
12.2.1 Abbott Company Details
12.2.2 Company Description and Business Overview
12.2.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.2.4 Abbott Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.2.5 Abbott Recent Development
12.3 AbbVie
12.3.1 AbbVie Company Details
12.3.2 Company Description and Business Overview
12.3.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.3.4 AbbVie Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.3.5 AbbVie Recent Development
12.4 Allergan
12.4.1 Allergan Company Details
12.4.2 Company Description and Business Overview
12.4.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.4.4 Allergan Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.4.5 Allergan Recent Development
12.5 Anterogen
12.5.1 Anterogen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.5.4 Anterogen Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.5.5 Anterogen Recent Development
12.6 Astellas Pharma
12.6.1 Astellas Pharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.6.4 Astellas Pharma Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.6.5 Astellas Pharma Recent Development
12.7 Athersys
12.7.1 Athersys Company Details
12.7.2 Company Description and Business Overview
12.7.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.7.4 Athersys Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.7.5 Athersys Recent Development
12.8 Caladrius
12.8.1 Caladrius Company Details
12.8.2 Company Description and Business Overview
12.8.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.8.4 Caladrius Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.8.5 Caladrius Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Company Details
12.9.2 Company Description and Business Overview
12.9.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.9.4 Eli Lilly Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.9.5 Eli Lilly Recent Development
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Company Details
12.10.2 Company Description and Business Overview
12.10.3 Graft Versus Host Disease (GVHD) Treatment Introduction
12.10.4 GlaxoSmithKline Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
12.10.5 GlaxoSmithKline Recent Development
12.11 Glenmark
12.12 Kadmon Holdings
12.13 Osiris Therapeutics
12.14 Sanofi
12.15 Shire
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Graft Versus Host Disease (GVHD) Treatment Key Market Segments
Table Key Players Graft Versus Host Disease (GVHD) Treatment Covered
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size Market Share by Type 2014-2025
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure MTOR Inhibitors Figures
Table Key Players of MTOR Inhibitors
Figure Tyrosine Kinase Inhibitors Figures
Table Key Players of Tyrosine Kinase Inhibitors
Figure Thalidomide Figures
Table Key Players of Thalidomide
Figure Etanercept Figures
Table Key Players of Etanercept
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Acute Graft Versus Host Disease (aGvHD) Case Studies
Figure Chronic Graft Versus Host Disease (cGvHD) Case Studies
Figure Graft Versus Host Disease (GVHD) Treatment Report Years Considered
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size 2014-2025 (Million US$)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Graft Versus Host Disease (GVHD) Treatment Market Share by Regions 2014-2019
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Share by Regions 2014-2019
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Graft Versus Host Disease (GVHD) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Graft Versus Host Disease (GVHD) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Share by Manufacturers in 2018
Table Global Graft Versus Host Disease (GVHD) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Graft Versus Host Disease (GVHD) Treatment Product/Solution/Service
Table Date of Enter into Graft Versus Host Disease (GVHD) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size Share by Type (2014-2019)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size Market Share by Type (2014-2019)
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size Share by Application (2014-2019)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Graft Versus Host Disease (GVHD) Treatment Revenue Market Share by Application in 2018
Figure United States Graft Versus Host Disease (GVHD) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Graft Versus Host Disease (GVHD) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Graft Versus Host Disease (GVHD) Treatment Market Share (2018-2019)
Table United States Graft Versus Host Disease (GVHD) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Graft Versus Host Disease (GVHD) Treatment Market Share by Type (2014-2019)
Table United States Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Graft Versus Host Disease (GVHD) Treatment Market Share by Application (2014-2019)
Figure Europe Graft Versus Host Disease (GVHD) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Graft Versus Host Disease (GVHD) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Graft Versus Host Disease (GVHD) Treatment Market Share (2018-2019)
Table Europe Graft Versus Host Disease (GVHD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Graft Versus Host Disease (GVHD) Treatment Market Share by Type (2014-2019)
Table Europe Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Graft Versus Host Disease (GVHD) Treatment Market Share by Application (2014-2019)
Figure China Graft Versus Host Disease (GVHD) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Graft Versus Host Disease (GVHD) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Graft Versus Host Disease (GVHD) Treatment Market Share (2018-2019)
Table China Graft Versus Host Disease (GVHD) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Graft Versus Host Disease (GVHD) Treatment Market Share by Type (2014-2019)
Table China Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Graft Versus Host Disease (GVHD) Treatment Market Share by Application (2014-2019)
Figure Japan Graft Versus Host Disease (GVHD) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Graft Versus Host Disease (GVHD) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Graft Versus Host Disease (GVHD) Treatment Market Share (2018-2019)
Table Japan Graft Versus Host Disease (GVHD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Graft Versus Host Disease (GVHD) Treatment Market Share by Type (2014-2019)
Table Japan Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Graft Versus Host Disease (GVHD) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Graft Versus Host Disease (GVHD) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Graft Versus Host Disease (GVHD) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Graft Versus Host Disease (GVHD) Treatment Market Share (2018-2019)
Table Southeast Asia Graft Versus Host Disease (GVHD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Graft Versus Host Disease (GVHD) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Graft Versus Host Disease (GVHD) Treatment Market Share by Application (2014-2019)
Figure India Graft Versus Host Disease (GVHD) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Graft Versus Host Disease (GVHD) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Graft Versus Host Disease (GVHD) Treatment Market Share (2018-2019)
Table India Graft Versus Host Disease (GVHD) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Graft Versus Host Disease (GVHD) Treatment Market Share by Type (2014-2019)
Table India Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Graft Versus Host Disease (GVHD) Treatment Market Share by Application (2014-2019)
Figure Central & South America Graft Versus Host Disease (GVHD) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Graft Versus Host Disease (GVHD) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Graft Versus Host Disease (GVHD) Treatment Market Share (2018-2019)
Table Central & South America Graft Versus Host Disease (GVHD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Graft Versus Host Disease (GVHD) Treatment Market Share by Type (2014-2019)
Table Central & South America Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Graft Versus Host Disease (GVHD) Treatment Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Abbott Company Details
Table Abbott Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)(Million US$)
Figure Abbott Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table Abbott Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Allergan Company Details
Table Allergan Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table Allergan Recent Development
Table Anterogen Company Details
Table Anterogen Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)(Million US$)
Figure Anterogen Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table Anterogen Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table Astellas Pharma Recent Development
Table Athersys Company Details
Table Athersys Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)(Million US$)
Figure Athersys Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table Athersys Recent Development
Table Caladrius Company Details
Table Caladrius Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)(Million US$)
Figure Caladrius Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table Caladrius Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Graft Versus Host Disease (GVHD) Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Glenmark Company Details
Table Kadmon Holdings Company Details
Table Osiris Therapeutics Company Details
Table Sanofi Company Details
Table Shire Company Details
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size Share by Regions (2019-2025)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size Share by Regions in 2025
Figure United States Graft Versus Host Disease (GVHD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Graft Versus Host Disease (GVHD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Graft Versus Host Disease (GVHD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Graft Versus Host Disease (GVHD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Graft Versus Host Disease (GVHD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Graft Versus Host Disease (GVHD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Graft Versus Host Disease (GVHD) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size by Product (2019-2025)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size by Product in 2025
Table Global Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size by Application (2019-2025)
Figure Global Graft Versus Host Disease (GVHD) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
宿主細胞汚染物質検査の世界市場：市場規模・現状・予測 Host cell proteins essentially refers to the heterogeneous group of proteins that are derived from host cells such as yeast, E-coli, and mammal, among others. They differ largely form each other in terms of properties, isoelectric point, and molecular mass. Identification and quantification of host …- 生分解性骨移植片ポリマーの世界市場：市場規模・現状・予測 Biodegradable Bone Graft Polymers is profoundly carving an evolution tale from conventional allogeneic and autologous bone grafting techniques to synthetic bone grafts, primarily on account of the biodegradability and biocompatibility properties of the latter. Synthetic bone graft polymers are capab…
- 皮膚移植の世界市場：市場規模・現状・予測 Skin grafting involves the transplantation of skin graft. The skin in form of a thin section is taken from a healthy part of the body or a full thickness skin graft, which involves slicing a thick entire skin section from the donor section.US accounts for the maximum market share due to favorable re…
- パーキンソン病治療の世界市場：市場規模・現状・予測 Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA)…
- mTOR阻害剤の世界市場：インサイト・予測 mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR).Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell …